Trial reportPloS one2026
Integrating multi-session transcranial direct current stimulation with routine physical therapy to improve quadriceps strength and activation in athletes during subacute recovery following ACL reconstruction: A double-blind RCT.
Trial report in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveAnterior cruciate ligament reconstruction (ACLR) is often associated with persistent quadriceps weakness and impaired voluntary activation. Integrating active anodal transcranial direct current stimulation (a-tDCS) with routine physical therapy (RPT) may offer additional neuromodulatory benefits during the subacute phase of rehabilitation in nonprofessional male athletes.
methodsTwenty male nonprofessional athletes (mean age: 27.50 ± 7.24 years, BMI: 25.83 ± 3.49) were randomly assigned to two groups: active M1 a-tDCS + RPT (n = 10) and sham M1 a-tDCS + RPT (n = 10). Both groups received 10 sessions of a-tDCS during RPT. The active group received 2 mA stimulation for 20 minutes per session, while the sham group received 2 mA for 30 seconds, followed by ramp-down and discontinuation. Quadriceps strength was measured using an isokinetic dynamometer, voluntary activation was assessed using the superimposed burst technique (Central Activation Ration (CAR) method) Baseline measurements were taken after 10 weeks of RPT, prior to the combined intervention phase.
resultsThe active a-tDCS group demonstrated a significant improvement in CAR compared to the sham group (mean difference: 6.85%; 95% CI: 1.92-11.77; p = 0.01), while the sham group showed a slight, non-significant decrease (2.54%; p = 0/80). Within-group analysis revealed significant voluntary activation improvements in the active group (p = 0.005), with no significant changes in the sham group (p = 0.59). No significant between-group differences in quadriceps strength were observed (p = 0.4), although both groups showed significant within-group improvements (active: 21.8%, P ≤ 0.001; sham: 14.8%, p = 0.02), likely due to the effects of RPT.
conclusionThe integration of multi-session a-tDCS with RPT during the subacute phase of ACLR recovery significantly enhanced voluntary activation and knee-specific function, as measured by the International Knee Documentation Committee (IKDC) score. These findings suggested that multiple-channel a-tDCS may facilitate neural activation and functional recovery, with clinically meaningful improvements in IKDC scores observed in the active group. Trial Registration: Iranian Registry of Clinical Trials (IRCT) Registration Number: IRCT20231113060048N1; Registered on December 28, 2023. URL: https://irct.behdasht.gov.ir/search/result?query=IRCT20231113060048N1.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.